TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 43.1 +0.70 (+1.65%) Aug 18
18.34
P/B:
12.74
Market Cap:
€ 6.64B ($ 7.69B)
Enterprise V:
€ 6.82B ($ 7.90B)
Volume:
0
Avg Vol (2M):
173.00
Trade In:

TG Therapeutics Inc Valuation Measures